Santen Pharmaceutical

Highly Engaged Employees

Santen Pharmaceutical is a specialized Japanese pharmaceutical entity founded in 1890, focusing exclusively on ophthalmology. The company maintains a dominant market share in Japan and operates as a global leader in ophthalmic care, distributing products across more than 50 countries. Their core business revolves around the development, production, and distribution of prescription pharmaceuticals and specialty eye care treatments.

With a workforce of 1,000-5,000 employees, the organization manages complex drug delivery systems and advanced production methodologies, including blow/fill/seal technology. The company operates 6 locations globally, supporting a robust pipeline of vision-related therapeutics. Meet Santen Pharmaceutical's team to understand the organizational structure and the scientific expertise driving their R&D initiatives. Their operational footprint spans Asia, Europe, and North America, ensuring consistent delivery of life cycle management solutions for various ocular diseases.

Santen Pharmaceutical continues to prioritize long-term vision health through early detection awareness and innovative medicine. As a publicly traded entity on the Tokyo Stock Exchange (TYO: 4536), the firm integrates sustainable practices, recently recognized in the Newsweek Top Green World 2025 list. Their commitment to well-being extends to comprehensive employee benefits, including professional development and flexible work arrangements. By leveraging advanced scientific research and a dedicated focus on eye health, the company maintains its competitive edge in the global healthcare sector, consistently addressing unmet medical needs through specialized therapeutic interventions.